Target Name: LOC107986770
NCBI ID: G107986770
Review Report on LOC107986770 Target / Biomarker Content of Review Report on LOC107986770 Target / Biomarker
LOC107986770
Other Name(s): LOC107986770 variant X1 | Uncharacterized LOC107986770, transcript variant X1 | uncharacterized LOC107986770

LOC107986770: A Potential Drug Target Or Biomarker

LOC107986770, also known as LOC107986770 variant X1, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the heat shock protein (HSP) family, which are proteins that are involved in the regulation of protein folding and stability. HSPs are highly conserved, with multiple species having similar structures and functions.

LOC107986770 is of particular interest as a potential drug target or biomarker because of its unique structure and expression patterns. The LOC107986770 protein has a calculated molecular weight of 43.9 kDa and a calculated pI of 6.5. It is expressed in a variety of tissues, including muscle, heart, liver, and brain. It is also highly expressed in the testes, which suggests that it may be involved in the regulation of testicular function.

One of the key features of LOC107986770 is its expression pattern. It is primarily expressed in the cytoplasm of cells, rather than the cell membrane or the cytoskeleton. This is consistent with its function as a protein involved in the regulation of protein folding and stability. Additionally, LOC107986770 is expressed in a variety of tissues, which suggests that it may be involved in the regulation of a wide range of cellular processes.

LOC107986770 has also been shown to play a role in a variety of cellular processes. For example, it has been shown to be involved in the regulation of protein stability and in the detoxification of harmful substances. Additionally, it has been shown to play a role in the regulation of cell growth and in the development of cancer.

As a potential drug target, LOC107986770 is of particular interest because of its involvement in a variety of cellular processes that may be targeted by small molecules. For example, LOC107986770 has been shown to be involved in the regulation of protein stability, which may make it a potential target for small molecules that can modulate protein stability. Additionally, LOC107986770 has been shown to play a role in the regulation of cell growth and in the development of cancer, which may make it a potential target for small molecules that can inhibit cell growth or promote cell death.

LOC107986770 is also of interest as a potential biomarker for a variety of diseases. For example, it has been shown to be involved in the regulation of protein stability, which may be involved in the development of a variety of diseases. Additionally, LOC107986770 has been shown to be expressed in a variety of tissues, which may make it a potential biomarker for a variety of diseases.

In conclusion, LOC107986770 is a protein that is of interest as a potential drug target or biomarker. Its unique structure and expression patterns, as well as its involvement in a variety of cellular processes, make it a potential target for small molecules. Additionally, its potential as a biomarker for a variety of diseases makes it a promising tool for the development of new therapies. Further research is needed to fully understand the role of LOC107986770 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC107986770

The "LOC107986770 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107986770 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299